StockClub

STAB

STABStatera Biopharma, Inc.$ --
Statera Biopharma, Inc.

Statera Biopharma, Inc.

STAB

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

analyticsEarnings Summary

FY2022 Q3Updated: 09/30/2022

Revenue

attach_money
1M USD
-

Operating Income

trending_up
-2M USD
-

Net Income

verified
-5M USD
-

EPS

paid
-0.1$
-

Revenue

$670,473

BEAT
$997,839
Q1
$768,827
Q2
$670,473
$670,473
Q3
$670,473
$2.4M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2022 Q3 YoY
- $-

Net Income

$-5.2M

MISS
$-8.9M
Q1
$-4.1M
Q2
$63.9M
$-5.2M
Q3
$63.9M
$-18.2M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2022 Q3 YoY
- $-

Surprise History

ActualEstimate
FY2021
$0

Future Forecast

No forecast data